SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-003908
Filing Date
2024-01-16
Accepted
2024-01-16 08:24:48
Documents
14
Period of Report
2024-01-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm243285d1_8k.htm   iXBRL 8-K 38098
2 EXHIBIT 99.1 tm243285d1_ex99-1.htm EX-99.1 17401
6 GRAPHIC tm243285d1_ex99-1img01.jpg GRAPHIC 2803
  Complete submission text file 0001104659-24-003908.txt   242787

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA eyen-20240116.xsd EX-101.SCH 3015
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE eyen-20240116_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eyen-20240116_pre.xml EX-101.PRE 22359
8 EXTRACTED XBRL INSTANCE DOCUMENT tm243285d1_8k_htm.xml XML 3308
Mailing Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017 813-766-9539
EYENOVIA, INC. (Filer) CIK: 0001682639 (see all company filings)

IRS No.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38365 | Film No.: 24533742
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)